ES, iPS, MSC, and AFS cells.
Stem cells exploitation for Pediatric Surgery: current research and perspective
Journal Pediatric Surgery International
Publisher Springer Berlin / Heidelberg
ISSN 0179-0358 (Print) 1437-9813 (Online) – DOI 10.1007/s00383-009-2478-8
SpringerLink Date Thursday, September 03, 2009
ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective
Michela Pozzobon1, Marco Ghionzoli2 and Paolo De Coppi2 Contact Information
(1) Stem Cell Processing Laboratory, Department of Pediatrics, University of Padova, Padova, Italy
(2) Surgery Unit, UCL Institute of Child Health & Great Ormond St Hospital, 30 Guilford Street, London, WC1N 1EH, UK
Accepted: 18 August 2009 Published online: 1 September 2009
Abstract Despite the advancements that have been made in treating infants with congenital malformations, these still represent a major cause of disease and death during the first years of life and childhood. Regeneration of natural tissue from living cells to restore damaged tissues and organs is the main purpose of regenerative medicine. This relatively new field has emerged by the combination of tissue engineering and stem cell transplantation as a possible strategy for the replacement of damaged organs or tissues. This review would like to offer an insight on the latest evolution of stem cells with a glance at their possible application for regenerative medicine, particularly in the Paediatric Surgery field.
Keywords Stem cells – Regenerative medicine – ES – iPS – MSC – AFS cells – Pediatric Surgery